Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita
暂无分享,去创建一个
S. Kojima | H. Muramatsu | Yoshiyuki Takahashi | N. Nishio | H. Yagasaki | A. Hama | A. Shimada | H. Ohashi | S. Doisaki
[1] J. Tolar,et al. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita , 2011, Bone Marrow Transplantation.
[2] B. Alter,et al. Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.
[3] F. Locatelli,et al. Bone marrow transplantation for inherited bone marrow failure syndromes. , 2010, Pediatric clinics of North America.
[4] A. Yoshimi,et al. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children , 2009, Pediatric transplantation.
[5] P. Rosenberg,et al. Cancer in dyskeratosis congenita. , 2009, Blood.
[6] I. Dokal,et al. Advances in the understanding of dyskeratosis congenita , 2009, British journal of haematology.
[7] J. Wagner,et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] T. Smolarek,et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome , 2008, Bone Marrow Transplantation.
[9] T. Vulliamy,et al. Inherited aplastic anaemias/bone marrow failure syndromes. , 2008, Blood reviews.
[10] P. Pagel,et al. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] J. de la Fuente,et al. Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation , 2007, Pediatric transplantation.
[12] M. Ayas,et al. Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low‐dose cyclophosphamide and anti‐thymocyte globulin , 2007, Pediatric blood & cancer.
[13] S. Kojima,et al. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. , 2006, Haematologica.
[14] J. Fournet,et al. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen , 2005, Bone Marrow Transplantation.
[15] F. Locatelli,et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.
[16] M. Ostronoff,et al. Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond–Blackfan anemia , 2004, Bone Marrow Transplantation.
[17] C. Schmidt,et al. Marrow transplantation for pancytopenia in dyskeratosis congenita , 1985, Blut.
[18] Y. Dror,et al. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita , 2003, Bone Marrow Transplantation.
[19] R. Storb,et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita , 2003, Bone Marrow Transplantation.
[20] C. Schmoor,et al. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] S. Perrotta,et al. Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine‐based reduced‐intensity conditioning regimen , 2002, British journal of haematology.
[22] K. Horibe,et al. Prospective monitoring of the Epstein–Barr virus DNA by a real‐time quantitative polymerase chain reaction after allogenic stem cell transplantation , 2001, British journal of haematology.
[23] T. Ekman,et al. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning , 2001, Bone Marrow Transplantation.
[24] M. Kletzel,et al. Hematopoietic stem‐cell transplantation using unrelated cord‐blood versus matched sibling marrow in pediatric bone marrow failure syndrome: One center’s experience , 1999, Pediatric transplantation.
[25] Yun-Fai Chris Lau,et al. BONE MARROW TRANSPLANT FOR DYSKERATOSIS CONGENITA , 1999, British journal of haematology.
[26] G. Ghahremani,et al. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation , 1999, Bone Marrow Transplantation.
[27] H. Esperou,et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita , 1998, British journal of haematology.
[28] T. Shimizu,et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.
[29] H. Deeg,et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita , 1996, British journal of haematology.
[30] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[31] L. Luzzatto,et al. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. , 1992, Blood.
[32] C. Loirat,et al. Case Reports LATE VASCULAR COMPLICATIONS AFTER BONE MARROW TRANSPLANTATION FOR DYSKERATOSIS CONGENITA , 1991, British journal of haematology.
[33] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.